Verapamil mitigates chloride and calcium bi-channelopathy in a myotonic dystrophy mouse model
Journal of Clinical Investigation · 2024
DOI: 10.1172/jci173576 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Clinical Investigation, 2024. Verfasst von Lily A Cisco und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Physiology. Hauptthemen laut MEDLINE: Myotonic Dystrophy, Myotonia, Channelopathies. Die Arbeit wurde bisher 27-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAMS NIH HHS, NCATS NIH HHS, NIGMS NIH HHS.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacology and Physiology.
- Department of Neurology.
- Center for RNA Biology, University of Rochester School of Medicine and Dentistry, Rochester, New York, USA.
Förderung
- NIAMS NIH HHS
- NCATS NIH HHS
- NIGMS NIH HHS
- NINDS NIH HHS
- NIDCR NIH HHS
- Myotonic Dystrophy Foundation
- National Center for Advancing Translational Sciences
- National Institutes of Health
Zitieren
APA
Cisco, L. A., Sipple, M. T., Edwards, K. M., Thornton, C. A., & Lueck, J. D. (2024). Verapamil mitigates chloride and calcium bi-channelopathy in a myotonic dystrophy mouse model. Journal of Clinical Investigation. https://doi.org/10.1172/jci173576
Vancouver
Cisco LA, Sipple MT, Edwards KM, Thornton CA, Lueck JD. Verapamil mitigates chloride and calcium bi-channelopathy in a myotonic dystrophy mouse model. Journal of Clinical Investigation. 2024. doi:10.1172/jci173576
BibTeX
@article{Cisco2024,
author = {Cisco, Lily A and Sipple, Matthew T and Edwards, Katherine M and Thornton, Charles A and Lueck, John D},
title = {Verapamil mitigates chloride and calcium bi-channelopathy in a myotonic dystrophy mouse model},
journal = {Journal of Clinical Investigation},
year = {2024},
doi = {10.1172/jci173576}
}
EUVIMED